Enliven Therapeutics Inc (ELVN)

Working Capital Ratio

98.13%

Quarterly · Period ending:

ELVN logo

ELVN Working Capital Ratio

Latest reported98.13%
ELVN Quarterly Working Capital Ratio (79.36% → 98.13%)
High-resolution chart · PNG

ELVN working capital ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Enliven Therapeutics Inc Working Capital Ratio — Quarterly
Period endingWorking Capital Ratio
98.1274%
97.16%
96.2496%
95.3467%
95.341%
92.6549%
92.7714%
91.6642%
90.5147%
91.0703%
88.373%
93.609%
94.9834%
94.7815%
81.6802%
87.996%
94.2597%
87.3814%
92.5774%
92.3216%
88.8447%
91.64%
92.6422%
94.2361%
94.9945%
95.0554%
79.3621%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.